These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17663792)

  • 21. Effects of chain length on the aggregation of model polyglutamine peptides: molecular dynamics simulations.
    Marchut AJ; Hall CK
    Proteins; 2007 Jan; 66(1):96-109. PubMed ID: 17068817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity.
    Burnett B; Li F; Pittman RN
    Hum Mol Genet; 2003 Dec; 12(23):3195-205. PubMed ID: 14559776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytoprotective role of ubiquitin against toxicity induced by polyglutamine-expanded aggregates.
    Bae JS; Ryu KY
    Biochem Biophys Res Commun; 2018 Jun; 500(2):344-350. PubMed ID: 29654755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ubiquitin-protein ligases Nedd4 and Nedd4-2 show similar ubiquitin-conjugating enzyme specificities.
    Fotia AB; Cook DI; Kumar S
    Int J Biochem Cell Biol; 2006 Mar; 38(3):472-9. PubMed ID: 16337426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies to Investigate Ubiquitination in Huntington's Disease.
    Sap KA; Reits EA
    Front Chem; 2020; 8():485. PubMed ID: 32596207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studying polyglutamine aggregation in Caenorhabditis elegans using an analytical ultracentrifuge equipped with fluorescence detection.
    Kokona B; May CA; Cunningham NR; Richmond L; Jay Garcia F; Durante JC; Ulrich KM; Roberts CM; Link CD; Stafford WF; Laue TM; Fairman R
    Protein Sci; 2016 Mar; 25(3):605-17. PubMed ID: 26647351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure and function of ubiquitin conjugating enzyme E2-25K: the tail is a core-dependent activity element.
    Haldeman MT; Xia G; Kasperek EM; Pickart CM
    Biochemistry; 1997 Aug; 36(34):10526-37. PubMed ID: 9265633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-free analysis of polyQ-dependent protein aggregation and its inhibition by chaperone proteins.
    Machida K; Shigeta T; Kobayashi A; Masumoto A; Hidaka Y; Imataka H
    J Biotechnol; 2016 Dec; 239():1-8. PubMed ID: 27702574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Ubiquitin-Proteasome System in Huntington's Disease: Are Proteasomes Impaired, Initiators of Disease, or Coming to the Rescue?
    Schipper-Krom S; Juenemann K; Reits EA
    Biochem Res Int; 2012; 2012():837015. PubMed ID: 23050151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of ubiquitin-coding genes in cadmium-induced protein ubiquitination in human proximal tubular cells.
    Lee JY; Tokumoto M; Fujiwara Y; Satoh M
    J Toxicol Sci; 2015 Dec; 40(6):901-8. PubMed ID: 26558471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modifiers of mutant huntingtin aggregation: functional conservation of C. elegans-modifiers of polyglutamine aggregation.
    Teuling E; Bourgonje A; Veenje S; Thijssen K; de Boer J; van der Velde J; Swertz M; Nollen E
    PLoS Curr; 2011 Aug; 3():RRN1255. PubMed ID: 21915392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ARI-1, an RBR family ubiquitin-ligase, functions with UBC-18 to regulate pharyngeal development in C. elegans.
    Qiu X; Fay DS
    Dev Biol; 2006 Mar; 291(2):239-52. PubMed ID: 16457801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.
    Lee WC; Yoshihara M; Littleton JT
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3224-9. PubMed ID: 14978262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulating huntingtin half-life alters polyglutamine-dependent aggregate formation and cell toxicity.
    Kaytor MD; Wilkinson KD; Warren ST
    J Neurochem; 2004 May; 89(4):962-73. PubMed ID: 15140195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neurodegenerative diseases regulated by ubiquitin-proteasome system].
    Hatakeyama S
    Rinsho Shinkeigaku; 2006 Nov; 46(11):890-2. PubMed ID: 17432211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of valosin-containing protein (VCP)/p97 in the formation and clearance of abnormal protein aggregates.
    Kobayashi T; Manno A; Kakizuka A
    Genes Cells; 2007 Jul; 12(7):889-901. PubMed ID: 17584300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-Terminal Ubiquitination of Amyloidogenic Proteins Triggers Removal of Their Oligomers by the Proteasome Holoenzyme.
    Ye Y; Klenerman D; Finley D
    J Mol Biol; 2020 Jan; 432(2):585-596. PubMed ID: 31518613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [E2 ubiquitin-conjugating enzymes: structures and functions].
    Tokunaga F
    Tanpakushitsu Kakusan Koso; 2006 Aug; 51(10 Suppl):1150-6. PubMed ID: 16922367
    [No Abstract]   [Full Text] [Related]  

  • 39. Strong aggregation and increased toxicity of polyleucine over polyglutamine stretches in mammalian cells.
    Dorsman JC; Pepers B; Langenberg D; Kerkdijk H; Ijszenga M; den Dunnen JT; Roos RA; van Ommen GJ
    Hum Mol Genet; 2002 Jun; 11(13):1487-96. PubMed ID: 12045202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling polyglutamine pathogenesis in C. elegans.
    Brignull HR; Morley JF; Garcia SM; Morimoto RI
    Methods Enzymol; 2006; 412():256-82. PubMed ID: 17046663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.